Using Assisted Partner Services for HIV Testing and the Treatment of Males and Their Female Sexual Partners: Protocol for an Implementation Science Study.

HIV testing and counseling assisted partner notification services implementation science linkage to care western Kenya

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
20 May 2021
Historique:
received: 26 01 2021
accepted: 12 04 2021
revised: 01 04 2021
entrez: 20 5 2021
pubmed: 21 5 2021
medline: 21 5 2021
Statut: epublish

Résumé

Despite the effective scale-up of HIV testing and treatment programs, only 75% of people living with HIV (PLWH) globally know their status, and this rate is lower among men. This highlights the importance of implementing HIV testing and linkage interventions with a high uptake in this population. In a cluster randomized controlled trial conducted in Kenya between 2013 and 2015, we found that assisted partner services (APS) for HIV-exposed partners of newly diagnosed PLWH safely reached more HIV-exposed individuals with HIV testing compared with client referral alone. However, more data are needed to evaluate APS implementation in a real-world setting. This study aims to evaluate the effectiveness, acceptability, fidelity, and cost of APS when integrated into existing HIV testing services (HTS) in Western Kenya. Our study team from the University of Washington and PATH is integrating APS into 31 health facilities in Western Kenya. We are enrolling females newly diagnosed with HIV (index clients) who consent to receiving APS, their male sexual partners, and female sexual partners of male sexual partners who tested HIV positive. Female index clients and sexual partners testing HIV positive will be followed up at 6 weeks, 6 months, and 12 months postenrollment to assess linkage to care, antiretroviral therapy initiation, and HIV viral load suppression. We will evaluate the acceptability, fidelity, and cost of real-world implementation of APS via in-depth interviews conducted with national, county, and subcounty-level policy makers responsible for HTS. Facility health staff providing HTS and APS, in addition to staff working with the study project team, will also be interviewed. We will also conduct direct observations of facility infrastructure and clinical procedures and extract data from the facilities and county and national databases. As of March 2020, we have recruited 1724 female index clients, 3201 male partners, and 1585 female partners. We have completed study recruitment as well as 6-week (2936/2973, 98.75%), 6-month (1596/1641, 97.25%), and 12-month (725/797, 90.9%) follow-up visits. Preliminary analyses show that facilities scaling up APS identify approximately 12-18 new HIV-positive males for every 100 men contacted and tested. We are currently completing the remaining follow-up interviews and incorporating an HIV self-testing component into the study in response to the COVID-19 pandemic. The results will help bridge the gap between clinical research findings and real-world practice and provide guidance regarding optimal strategies for APS integration into routine HIV service delivery. DERR1-10.2196/27262.

Sections du résumé

BACKGROUND BACKGROUND
Despite the effective scale-up of HIV testing and treatment programs, only 75% of people living with HIV (PLWH) globally know their status, and this rate is lower among men. This highlights the importance of implementing HIV testing and linkage interventions with a high uptake in this population. In a cluster randomized controlled trial conducted in Kenya between 2013 and 2015, we found that assisted partner services (APS) for HIV-exposed partners of newly diagnosed PLWH safely reached more HIV-exposed individuals with HIV testing compared with client referral alone. However, more data are needed to evaluate APS implementation in a real-world setting.
OBJECTIVE OBJECTIVE
This study aims to evaluate the effectiveness, acceptability, fidelity, and cost of APS when integrated into existing HIV testing services (HTS) in Western Kenya.
METHODS METHODS
Our study team from the University of Washington and PATH is integrating APS into 31 health facilities in Western Kenya. We are enrolling females newly diagnosed with HIV (index clients) who consent to receiving APS, their male sexual partners, and female sexual partners of male sexual partners who tested HIV positive. Female index clients and sexual partners testing HIV positive will be followed up at 6 weeks, 6 months, and 12 months postenrollment to assess linkage to care, antiretroviral therapy initiation, and HIV viral load suppression. We will evaluate the acceptability, fidelity, and cost of real-world implementation of APS via in-depth interviews conducted with national, county, and subcounty-level policy makers responsible for HTS. Facility health staff providing HTS and APS, in addition to staff working with the study project team, will also be interviewed. We will also conduct direct observations of facility infrastructure and clinical procedures and extract data from the facilities and county and national databases.
RESULTS RESULTS
As of March 2020, we have recruited 1724 female index clients, 3201 male partners, and 1585 female partners. We have completed study recruitment as well as 6-week (2936/2973, 98.75%), 6-month (1596/1641, 97.25%), and 12-month (725/797, 90.9%) follow-up visits. Preliminary analyses show that facilities scaling up APS identify approximately 12-18 new HIV-positive males for every 100 men contacted and tested. We are currently completing the remaining follow-up interviews and incorporating an HIV self-testing component into the study in response to the COVID-19 pandemic.
CONCLUSIONS CONCLUSIONS
The results will help bridge the gap between clinical research findings and real-world practice and provide guidance regarding optimal strategies for APS integration into routine HIV service delivery.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/27262.

Identifiants

pubmed: 34014172
pii: v10i5e27262
doi: 10.2196/27262
pmc: PMC8176338
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e27262

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States

Informations de copyright

©Edward Kariithi, Monisha Sharma, Emily Kemunto, Harison Lagat, George Otieno, Beatrice M Wamuti, David A Katz, Christopher Obong'o, Paul Macharia, Rose Bosire, Sarah Masyuko, Mary Mugambi, Carol E Levin, Wenjia Liu, Unmesha Roy Paladhi, Bryan J Weiner, Carey Farquhar. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 20.05.2021.

Références

J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25310
pubmed: 31321902
Am J Public Health. 2003 Aug;93(8):1261-7
pubmed: 12893608
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):437-42
pubmed: 22046601
AIDS Behav. 2020 Nov;24(11):3010-3013
pubmed: 32488552
AIDS. 2018 Jan 14;32(2):233-241
pubmed: 29135576
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25314
pubmed: 31321909
Health Policy Plan. 2014 Jan;29(1):115-26
pubmed: 23325584
PLoS Med. 2012 Feb;9(2):e1001167
pubmed: 22346735
N Engl J Med. 2015 Aug 27;373(9):808-22
pubmed: 26193126
Lancet HIV. 2017 Feb;4(2):e74-e82
pubmed: 27913227
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25321
pubmed: 31321918
Sex Transm Dis. 2016 Nov;43(11):690-695
pubmed: 27893598
Open AIDS J. 2016 Apr 08;10:34-48
pubmed: 27347270
PLoS Med. 2017 Apr 11;14(4):e1002262
pubmed: 28399122
AIDS. 2017 Aug 24;31(13):1867-1876
pubmed: 28590326
PLoS Med. 2013 Aug;10(8):e1001496
pubmed: 23966838
PLoS Negl Trop Dis. 2008 Apr 30;2(4):e174
pubmed: 18446203
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25305
pubmed: 31321887
BMC Public Health. 2013 Mar 11;13:220
pubmed: 23497196

Auteurs

Monisha Sharma (M)

Department of Global Health, University of Washington, Seattle, WA, United States.

Beatrice M Wamuti (BM)

Department of Global Health, University of Washington, Seattle, WA, United States.

David A Katz (DA)

Department of Global Health, University of Washington, Seattle, WA, United States.

Christopher Obong'o (C)

Department of Global Health, University of Washington, Seattle, WA, United States.

Paul Macharia (P)

Department of Global Health, University of Washington, Seattle, WA, United States.

Rose Bosire (R)

Kenya Medical Research Institute, Nairobi, Kenya.

Sarah Masyuko (S)

Department of Global Health, University of Washington, Seattle, WA, United States.
Ministry of Health, Nairobi, Kenya.

Mary Mugambi (M)

Ministry of Health, Nairobi, Kenya.

Carol E Levin (CE)

Department of Global Health, University of Washington, Seattle, WA, United States.

Wenjia Liu (W)

School of Nursing, University of Washington, Seattle, WA, United States.

Unmesha Roy Paladhi (U)

Department of Global Health, University of Washington, Seattle, WA, United States.
Department of Epidemiology, University of Washington, Seattle, WA, United States.

Bryan J Weiner (BJ)

Department of Global Health, University of Washington, Seattle, WA, United States.

Carey Farquhar (C)

Department of Global Health, University of Washington, Seattle, WA, United States.
Department of Epidemiology, University of Washington, Seattle, WA, United States.

Classifications MeSH